Drugs / Exosomes derived from umbilical cord mesenchymal stem cell
Exosomes derived from umbilical cord mesenchymal stem cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07457125 | May 2026 → Dec 2028 expected | — | Xuanwu Hospital, Beijing | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Exosomes derived from umbilical cord mesenchymal stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07457125 ↗ |
| Modality | Other / unclassified | “Exosomes derived from umbilical cord mesenchymal stem cell for intranasal drop” NCT07457125 ↗ |
| Route | Intranasal | “Patients in this group will receive intranasal drops of exosomes derived from umbilical cord mesenchymal stem cells, twice weekly for 12 weeks.” NCT07457125 ↗ |